180: A Successful Treatment Strategy for Patients with T-NHL: Allogeneic Transplantation after Beam-Alemtuzumab Conditioning

MLA

André Schrauder, et al. “180: A Successful Treatment Strategy for Patients with T-NHL: Allogeneic Transplantation after Beam-Alemtuzumab Conditioning.” Biology of Blood and Marrow Transplantation, vol. 14, Feb. 2008, p. 66. EBSCOhost, https://doi.org/10.1016/j.bbmt.2007.12.189.

APA

André Schrauder, Andreas Humpe, H. Schade, Martin Gramatzki, & Roland Repp. (2008). 180: A Successful Treatment Strategy for Patients with T-NHL: Allogeneic Transplantation after Beam-Alemtuzumab Conditioning. Biology of Blood and Marrow Transplantation, 14, 66. https://doi.org/10.1016/j.bbmt.2007.12.189

Chicago

André Schrauder, Andreas Humpe, H. Schade, Martin Gramatzki, and Roland Repp. 2008. “180: A Successful Treatment Strategy for Patients with T-NHL: Allogeneic Transplantation after Beam-Alemtuzumab Conditioning.” Biology of Blood and Marrow Transplantation 14 (February): 66. doi:10.1016/j.bbmt.2007.12.189.